Core Viewpoint - A securities fraud class action lawsuit has been filed against C3.ai, Inc. alleging misrepresentations regarding the company's business and the impact of the CEO's health on its operations [2][3]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Northern District of California on behalf of investors who acquired C3 securities between February 26, 2025, and August 8, 2025 [2]. - Allegations include that the CEO's health significantly affected C3 AI's ability to close deals and that management failed to mitigate this impact, hindering the company's profit and growth potential [3]. Group 2: Legal Representation - Investors wishing to serve as lead plaintiffs must file by October 21, 2025, with the option to remain absent class members without affecting their ability to share in any recovery [4]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [5]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" and listed in The Legal 500 for sixteen consecutive years [5].

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of SelectQuote, Inc. (NYSE: SLQT)?Did you purchase your shares between September 9, 2020 and May 1, 2025, inclusive?Did you lose money in your investment in SelectQuote, Inc.?Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) investors of an upcoming deadline involving a securities ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our t ...

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. Accessibility StatementSkip Navigation NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Dow Inc. ("Dow Inc." or the "Company") (NYSE: DOW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Dow Inc. investors who were adversely affected by alle ...

Core Viewpoint - A class action securities lawsuit has been filed against Sable Offshore Corp. due to alleged securities fraud affecting investors who purchased shares between May 19, 2025, and June 3, 2025, and those involved in the company's secondary public offering on May 21, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Sable Offshore Corp. misrepresented its oil production status off the coast of California, stating that production had restarted when it had not [3]. - The complaint alleges that the defendants' statements regarding the company's business operations and prospects were materially false and misleading, lacking a reasonable basis [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until September 26, 2025, to request appointment as lead plaintiff, although participation does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - Altimmune, Inc. is facing a class action securities lawsuit due to alleged securities fraud that affected investors between August 10, 2023, and June 25, 2025 [1][2] Case Details - On June 26, 2025, Altimmune announced topline results from the IMPACT Phase 2b MASH trial of Pemvidutide, which failed to achieve statistical significance in the primary endpoint of fibrosis reduction [2] - The stock price of Altimmune dropped from $7.71 per share on June 25, 2025, to $3.61 per share on June 26, 2025, marking a decline of 53.2% in one day [2] Next Steps - Investors who suffered losses during the specified timeframe have until October 6, 2025, to request appointment as lead plaintiff, although participation does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Why Levi & Korsinsky - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as a leading securities litigation firm in the U.S. [4]

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lantheus investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/lantheus-holding ...

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in PubMatic, Inc. ("PubMatic, Inc." or the "Company") (NASDAQ: PUBM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PubMatic, Inc. investors who were adversely affected by alleged securities fraud between February 27, 2025 and August 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/pubmatic-inc ...

Accessibility StatementSkip Navigation BENSALEM, Pa., Sept. 25, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against CTO Realty Growth, Inc. ("CTO" or the "Company") (NYSE:Â CTO). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CTO REALTY GROWTH, INC. (CTO), CONTACT THE LAW OFFICES OF HOWARD G. SMITHÂ BEFORE OCTOBER 7, 2025(LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURI ...

Core Viewpoint - Investors in LifeMD, Inc. have the opportunity to lead a securities fraud class action lawsuit due to substantial losses incurred as a result of misleading statements made by the company's management regarding its competitive position and financial guidance [1][3]. Group 1: Lawsuit Details - The lawsuit alleges that from May 7, 2025, to August 5, 2025, LifeMD's management materially overstated the company's competitive position [3]. - It is claimed that the management was reckless in raising LifeMD's 2025 guidance without properly accounting for rising customer acquisition costs in its RexMD segment and related to obesity treatment drugs [3]. - The positive statements made by the defendants about LifeMD's business operations and prospects were materially misleading and lacked a reasonable basis during the relevant period [3]. Group 2: Participation Information - Investors who suffered losses in LifeMD, Inc. are encouraged to contact the Law Offices of Howard G. Smith before October 27, 2025, to participate in the ongoing lawsuit [2][4]. - Interested parties can reach out via email, telephone, or visit the law firm's website for more information regarding their legal rights [2][4].